Skip to main content
In medicine, a field where burnout is becoming the norm, there is much promotion of the idea of work-life balance. In reality, the scales between work and life aren’t really balanced. Is the potential for change on the horizon?
Doctors - How wide is your network of colleagues?

Dr. John Cush RheumNow

3 years 4 months ago
Doctors - How wide is your network of colleagues?
Having their clinics shut down and patients staying away during the COVID-19 pandemic was bad enough for physicians' finances, but now a new study finds that, at least for rheumatologists, payments from industry dried up as well.
Women are 80% of healthcare workforce; 97% of EU nurses & midwives are women- yet women earn 24% less than men &

Dr. John Cush RheumNow

3 years 4 months ago
Women are 80% of healthcare workforce; 97% of EU nurses & midwives are women- yet women earn 24% less than men & hold 25% of senior roles in the health sector. WHO officials call for equal pay/promotion, better work conditions &gender specific solutions https://t.co/ccuFnTmnvF https://t.co/V03RnXB1JE
2023 NRMP Match: 365 applicants for Rheum; 97.8% (265 of 271 avail) of Adult Rheum fellow positions matched (only 4/127

Dr. John Cush RheumNow

3 years 4 months ago
2023 NRMP Match: 365 applicants for Rheum; 97.8% (265 of 271 avail) of Adult Rheum fellow positions matched (only 4/127 programs did not fill their match). Pediatric Rheum 27/41 positions (62.8%)were filled (14/32 programs not filling). https://t.co/VECH6rMHBV https://t.co/MC1jhLCQBk
Gender Norms in Chronic Pain

Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwar

Dr. John Cush RheumNow

3 years 4 months ago
Gender Norms in Chronic Pain Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment may result, as a University of Gothenburg doctoral thesis emphasizes. https://t.co/HcCURc0fMz https://t.co/ZWNk5D3JvH
Watch Dr. Alexis Ogdie discuss sex differences in axSpA, addressing disease susceptibility and outcomes, prevalence rati

Dr. John Cush RheumNow

3 years 4 months ago
Watch Dr. Alexis Ogdie discuss sex differences in axSpA, addressing disease susceptibility and outcomes, prevalence ratios, differences in PROs and the latest research. https://t.co/ldQRGBX1g1 https://t.co/XVRZ3wjG7M
Our next Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, M

Dr. John Cush RheumNow

3 years 4 months ago
Our next Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD. Sign up to attend this and all of our Tuesday Night Rheumatology series. @uptoTate @KDAO2011 https://t.co/ooO4ZcneLB https://t.co/eNUkqljtpj
Friday's podcast "You Can Have it All” is out now and available for download.

Dr. Jack Cush reviews the news and hig

Dr. John Cush RheumNow

3 years 4 months ago
Friday's podcast "You Can Have it All” is out now and available for download. Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow. https://t.co/ugZNDqfvsB https://t.co/kNkVwIAlJ5
I recently sat down with Dr. Daniel Battafarano, chair of the ACR’s Workforce Solutions Committee, to discuss workforce study findings, their impact on the next few years, and proposed interventions to address these issues.
2022 Doximity Physician salary survey shows that among the least paid specialties; Pediatric rheumatology was #3 at $226

Dr. John Cush RheumNow

3 years 4 months ago
2022 Doximity Physician salary survey shows that among the least paid specialties; Pediatric rheumatology was #3 at $226k and Adult Rheumatology was #20 at $299K https://t.co/HL7vReY6Vg https://t.co/LbWQ9IBUWr
British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline

BSR last published its guideline for SS

Dr. John Cush RheumNow

3 years 5 months ago
British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline BSR last published its guideline for SSc in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc. https://t.co/s4AKdVS2H7 https://t.co/MmIGw2QLEn
Inflammasome inhibitors in development:
- RRx-001 in cancer, ALS, parkinsons
- OLT1177 in OA knee, gout, Schnitzlers
- D

Dr. John Cush RheumNow

3 years 5 months ago
Inflammasome inhibitors in development: - RRx-001 in cancer, ALS, parkinsons - OLT1177 in OA knee, gout, Schnitzlers - DFV890 in CAPs, knee OA - IZD174/334 in CAPS - ZYIL1 CAPS https://t.co/1oCmKIHchP https://t.co/Y8CBAx2T7w
×